Immunocore Holdings plc (IMCR)

Immunocore Holdings Revenue

Immunocore Holdings had revenue of $264.25M in the twelve months ending March 31, 2024, with 31.52% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $70.50M with 28.99% year-over-year growth. In the year 2023, Immunocore Holdings had annual revenue of $249.43M with 43.05% growth.

• Revenue (ttm): $264.25M
• Revenue Growth: +31.52%
• P/S Ratio: 7.53
• Revenue / Employee: $531,698
• Employees: 497
• Market Cap: 1.99B USD

Revenue Chart

* The company reports in GBP currency but revenue data is shown in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	249.43M	75.07M	43.05%
Dec 31, 2022	174.36M	137.88M	377.91%
Dec 31, 2021	36.48M	-1.16M	-3.08%
Dec 31, 2020	37.64M	5.56M	17.32%
Dec 31, 2019	32.09M	2.52M	8.52%
Dec 31, 2018	29.57M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.